| Hussein Adly, MD | |
|
335 Glessner Ave, Mansfield, OH 44903-2269 | |
| (419) 522-2734 | |
| Not Available |
| Full Name | Hussein Adly |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 13 Years |
| Location | 335 Glessner Ave, Mansfield, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013460575 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 35.141742 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohiohealth Mansfield Hospital | Mansfield, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohiohealth Corporation | 6305758426 | 1900 |
News Archive
Rates of serious mental illness among university students are drastically rising, and universities are struggling with how to respond to students who show symptoms. Traumatic situations such as academics, financial problems, family problems, intimate and other relationship issues, and career related issues are leaving students overwhelmed, exhausted, sad, lonely, hopeless and depressed.
Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into the risks associated with isolated mild hyperglycemia, according to a study in the January 15 issue of JAMA.
The following factors facilitate the formation of putatively toxic structures in the neuronal nuclei of Alzheimer's patients.
Emergent BioSolutions Inc. today announced that it presented preclinical data on its lead bispecific ADAPTIRTM (Modular Protein Technology) molecule, ES414, at the 9th Annual Protein and Antibody Engineering Summit, currently underway in Boston, MA.
› Verified 1 days ago
| Entity Name | Ohiohealth Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
Rates of serious mental illness among university students are drastically rising, and universities are struggling with how to respond to students who show symptoms. Traumatic situations such as academics, financial problems, family problems, intimate and other relationship issues, and career related issues are leaving students overwhelmed, exhausted, sad, lonely, hopeless and depressed.
Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into the risks associated with isolated mild hyperglycemia, according to a study in the January 15 issue of JAMA.
The following factors facilitate the formation of putatively toxic structures in the neuronal nuclei of Alzheimer's patients.
Emergent BioSolutions Inc. today announced that it presented preclinical data on its lead bispecific ADAPTIRTM (Modular Protein Technology) molecule, ES414, at the 9th Annual Protein and Antibody Engineering Summit, currently underway in Boston, MA.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hussein Adly, MD Po Box 7527, Dublin, OH 43017-0727 Ph: () - | Hussein Adly, MD 335 Glessner Ave, Mansfield, OH 44903-2269 Ph: (419) 522-2734 |
News Archive
Rates of serious mental illness among university students are drastically rising, and universities are struggling with how to respond to students who show symptoms. Traumatic situations such as academics, financial problems, family problems, intimate and other relationship issues, and career related issues are leaving students overwhelmed, exhausted, sad, lonely, hopeless and depressed.
Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into the risks associated with isolated mild hyperglycemia, according to a study in the January 15 issue of JAMA.
The following factors facilitate the formation of putatively toxic structures in the neuronal nuclei of Alzheimer's patients.
Emergent BioSolutions Inc. today announced that it presented preclinical data on its lead bispecific ADAPTIRTM (Modular Protein Technology) molecule, ES414, at the 9th Annual Protein and Antibody Engineering Summit, currently underway in Boston, MA.
› Verified 1 days ago
Mary E. Alton, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 419-524-8151 | |
Prity S Vaidya, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave Ste 1430, Mansfield, OH 44903 Phone: 419-526-8044 Fax: 419-526-8854 | |
Dr. Jagprit Singh Dhillon, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 216-924-1151 | |
James P. Bacon, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 419-524-8151 | |
Dr. Ryan C Kamp, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 419-526-8000 | |
Dr. Laura L Weakland, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 335 Glessner Ave, Mansfield, OH 44903 Phone: 419-756-2003 |